| Price | 11.50p on 05-12-2025 at 19:00:08 |
|---|---|
| Change | 0.20p 1.77% |
| Buy | 11.80p |
| Sell | 11.20p |
| Last Trade: | Buy 172.00 at 11.59p |
| Day's Volume: | 1,300,693 |
| Last Close: | 11.50p |
| Open: | 11.20p |
| ISIN: | GB00BYV81293 |
| Day's Range | 10.95p - 11.50p |
| 52wk Range: | 2.20p - 12.35p |
| Market Capitalisation: | £122.11m |
| VWAP: | 11.26919p |
| Shares in Issue: | 1.06b |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Shield Thera (STX) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 172 | 11.59p | Ordinary |
16:13:26 - 05-Dec-25 |
| Sell* | 525 | 11.20p | Ordinary |
16:04:07 - 05-Dec-25 |
| Sell* | 15,000 | 11.475p | Ordinary |
16:02:23 - 05-Dec-25 |
| Sell* | 200 | 11.20p | SI Trade |
16:02:11 - 05-Dec-25 |
| Buy* | 85 | 11.80p | SI Trade |
16:02:11 - 05-Dec-25 |
| Buy* | 200 | 11.80p | SI Trade |
16:02:11 - 05-Dec-25 |
| Buy* | 4,237 | 11.80p | SI Trade |
16:02:11 - 05-Dec-25 |
| Buy* | 9 | 11.80p | SI Trade |
16:02:11 - 05-Dec-25 |
| Sell* | 250 | 11.20p | SI Trade |
16:02:11 - 05-Dec-25 |
| Sell* | 259 | 11.20p | SI Trade |
16:02:11 - 05-Dec-25 |
Shield Thera (STX) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 3rd Dec 2025 7:04 am | RNS | Amends Senior Secured Debt Financing |
| 14th Nov 2025 7:03 am | RNS | Initiation of a Phase II Clinical Trial in Japan |
| 11th Nov 2025 7:00 am | RNS | ACCRUFeR Pediatric PK Results to be Presented |
| 7th Nov 2025 7:03 am | RNS | ACCRUFeR receives Authorisation by Korean Ministry |
| 23rd Oct 2025 7:00 am | RNS | Q3 2025 Trading Update |
| 14th Oct 2025 3:01 pm | RNS | Grant of Share Options to Chief Executive Officer |
| 1st Oct 2025 8:00 am | RNS | Total Voting Rights |
| 1st Oct 2025 7:02 am | RNS | Positive efficacy and tolerance in pediatric trial |
| 15th Sep 2025 7:00 am | RNS | £1.5 million placing supporting growth of ACCRUFeR |
| 4th Sep 2025 7:03 am | RNS | ACCRUFeR® assigned Priority Review in US by FDA |
